Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A study in healthy people to test whether iclepertin has an effect on cardiac safety Ended

2023-504693-38-00 Healthy 2024-01-25
Evaluation of the effect of CHF6795 on the pharmacokinetics of midazolam, repaglinide and rosuvastatin in healthy subjects Ended

2023-507997-41-00 Chronic cough 2024-01-25
A study to learn how BAY2927088 is taken up and handled by the body in healthy male participants Ended

2022-502771-38-00 Advanced non-small cell lung cancer with EGFR and/or HE 2024-01-24
Phase 1b safety study of xevinapant, weekly cisplatin, and radiotherapy in participants with unresected LA SCCHN Ended

2023-505796-76-00 Locally Advanced Squamous Cell Carcinoma of the Head an 2024-01-18
Phase 0 lead-in trial of Pitavastatin in primary and recurrent Glioblastoma patients Ended

2023-505743-38-00 Glioblastoma Multiforme 2024-01-18
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685… Ended

2023-506367-33-00 Healthy volunteer trial 2024-01-16
A randomized, Phase 1b, single-center, observer-blind, active-controlled study to evaluate the safety, immunogenicity, and immunological mec… Ended

2023-508230-33-00 Influenza 2024-01-12
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment Ended

2023-503919-15-00 Prostatic Neoplasms 2024-01-09
A phase 1, randomised, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study to evaluate the safety, tol… Ended

2023-506912-41-00 Idiopathic pulmonary fibrosis 2024-01-09
A study to evaluate how the body absorbs, breaks down and removes drug as well as safety and tolerability when two drugs are administered to… Ended

2023-506580-34-00 Healthy Volunteers 2024-01-04
A clinical trial to learn how an investigational drug (vimseltinib) is absorbed, distributed, broken down, and removed from the body when gi… Ended

2023-503415-15-00 Tenosynovial Giant Cell Tumor (TGCT) 2023-12-21
A Sub Study to Learn About the Study Medication Called Etrasimod Tablets in a Hybrid Decentralized Clinical Trial Setting Ended

2023-508119-22-00 immune-mediated inflammatory disorders, including ulcer 2023-12-18
A Study to Learn How Different Amounts of the Study Medicine Called PF-07293893 are Tolerated and Act in the Body of Healthy Adults. Ended

2023-508171-36-00 heart failure with preserved ejection fraction 2023-12-15
A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion … Ended

2024-512624-11-00 Duchenne muscular dystrophy (DMD) 2023-12-15
A study to investigate the mass balance, absolute bioavailability (BA), pharmacokinetics (PK), and metabolism of a single oral dose 60 mg [1… Ended

2023-506044-16-00 There is no medical condition being investigated. 2023-12-14
Imatinib PD in healthy subjects Ended

2023-504958-35-00 Immuno-oncology assessments 2023-12-13
A study in healthy men to test how BI 1291583 is taken up by the body Ended

2023-505683-11-00 Healthy volunteer trial 2023-12-12
A multicenter, Phase 1b, double-blind, placebo-controlled study to evaluate the safety and tolerability, and the efficacy of si-544 in adult… Ended

2023-507393-40-00 psoriasis vulgaris 2023-12-12
A study to investigate the pharmacokinetics of remibrutinib in CSF in healthy participants. Ended

2023-506760-13-00 Healthy 2023-12-11
A study in women with overweight or obesity to test whether different doses of BI 456906 influence the amount of a contraceptive in the bloo… Ended

2022-503146-53-00 pharmacokinetic trial 2023-12-07
An Open-label, Single-dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Aticaprant (JNJ-67953964) Ended

2023-503258-11-00 Healthy Adult Participants 2023-12-06
A study to assess the pharmacokinetics, and glucodynamics of LY3209590 in participants with type 2 diabetes Ended

2023-508008-39-00 Type 2 Diabetes Mellitus 2023-12-05
Randomized, non-comparative, open-label early phase Ib study with OBT076 or OBT076 followed by Balstilimab in patients with Adenoid Cystic C… Ended

2023-503270-20-00 recurrent or metastatic Adenoid Cystic Carcinoma of the 2023-11-29
Pharmacokinetics of Nicorandil 40 mg Extended-Release Capsules in Healthy Subjects Under Fasting and Fed Conditions. Ended

2023-506085-31-00 No medical condition. 2023-11-27